<Anchor>
In the midst of this, Pfizer vaccine approval for children aged 5 to 11 was issued yesterday.
Vaccinations will begin as early as next month, so let's talk about whether children should get it right or not, with medical reporter Cho Dong-chan.
Let's start with how effective the vaccine for children is and how safe it is.
<Reporter> We
will show you the data from the US Centers for Disease Control and Prevention.
Since 8.7 million doses were administered, two doses would have resulted in 4.35 million children.
100 cases of serious adverse reactions such as fever and redness.
Of these, 12 cases of heart inflammation were recovered.
The infection prevention effect is 90.7%.
It works and is considered safe.
Vaccination is also recommended in the European Union, the United States, Canada and Australia.
There are opposing opinions.
A British-Swiss joint study found that children were so mild that there was insufficient evidence to determine whether vaccination would benefit them.
Sweden decided not to guess.
However, the UK and Belgium, which were worried about, have recently changed to a correct guess.
Unlike adults, which kills 1 in 60 infected people worldwide, 1 in 3,500 children die, which is only 1/60 of the adult fatality rate.
If the number of children infected is small, there is no benefit, but if the number of children infected increases, the benefit is great.
However, there is no vaccine pass that forces children to be vaccinated.
It's up to your choice.
<Anchor>
Even if children get the vaccine, they only get it in March, so there was some point out that the vaccination might be effective after the peak of Omicron is over.
<Reporter> It
should be the middle of next month at the earliest.
You will be given 2 doses at 3 week intervals to develop immunity after 2 weeks, so you will not see the effect until the end of April.
By that time, the peak of fashion would have passed.
However, the UK and Belgium also decided to vaccinate children after peaking.
This is in consideration of a recent study suggesting that the vaccine would have a severe preventive effect against another possible mutation.
<Anchor>
And in the meantime, tens of thousands of children have been confirmed, is it okay to not get the vaccine in this case?
<Reporter>
Since there is no specific data on this, I asked an expert from the Korean Vaccine Society about what it is like for children.
You answered that there is no evidence that there is no benefit in getting another vaccine for an infected child.
It doesn't have to be right for now.
Natural immunity develops after infection, but it cannot be said that the immunity generated by another vaccine is more effective than the natural immunity in children.
<Anchor>
There is a lot of interest in the Novavax vaccine these days, but there have been many questions about whether it is not suitable for children.
<Reporter>
Clinical trials for 12 to 17-year-olds have almost completed.
They say they are preparing to apply for a permit.
For ages 5-11, the exam is still in progress.
The permit is expected to be issued in at least three months.
▶ 4 months and 7-year-olds also died from Corona...
"I will set up a hotline"